Interactions of Multitargeted Kinase Inhibitors and Nucleoside Drugs: Achilles Heel of Combination Therapy?
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-14-0337
Full Text
Open PDFAbstract
Available in full text
Date
December 17, 2014
Authors
Publisher
American Association for Cancer Research (AACR)